
/Users/nsuaifan/Desktop/sample/WATSON PHARMACEUTICALS 2003 Q4.txt
________________
 
FD (FAIR DISCLOSURE) WIRE
 
PATRICIA EISENHAUR, DIRECTOR OF INVESTOR RELATIONS, WATSON PHARMACEUTICALS INC.
 
 
 
 
 
ALLEN CHAO, CHAIRMAN AND CEO, WATSON PHARMACEUTICALS INC.
 
 
 
 
 
 
 
 
 
JOSEPH PAPA, PRESIDENT AND COO, WATSON PHARMACEUTICALS INC.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHARLES EBERT, SENIOR VICE PRESIDENT OF RESEARCH AND DEVELOPMENT, WATSON PHARMACEUTICALS INC.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHARLES SLACIK, CFO, WATSON PHARMACEUTICALS INC.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ALLEN CHAO
 
 
 
ANALYST
 
CORPORATE PARTICIPANT
 
CORPORATE PARTICIPANT
 
ANALYST
 
CORPORATE PARTICIPANT
 
ANALYST
 
CORPORATE PARTICIPANT
 
ANALYST
 
CHARLES EBERT
 
CORPORATE PARTICIPANT
 
ANALYST
 
CORPORATE PARTICIPANT
 
ANALYST
 
CORPORATE PARTICIPANT
 
CORPORATE PARTICIPANT
 
OPERATOR
 
KIM RECOCK, ANALYST
 
CORPORATE PARTICIPANT
 
KIM RECOCK
 
CORPORATE PARTICIPANT
 
OPERATOR
 
IAN SANDERSON, ANALYST
 
CORPORATE PARTICIPANT
 
ANALYST
 
CORPORATE PARTICIPANT
 
CORPORATE PARTICIPANT
 
ANALYST
 
CORPORATE PARTICIPANT
 
ANALYST
 
CORPORATE PARTICIPANT
 
ANALYST
 
CORPORATE PARTICIPANT
 
ANALYST
 
CORPORATE PARTICIPANT
 
CORPORATE PARTICIPANT
 
ANALYST
 
CORPORATE PARTICIPANT
 
ANALYST
 
CORPORATE PARTICIPANT
 
 
ANALYST
 
ANALYST
 
CORPORATE PARTICIPANT
 
ANALYST
 
CORPORATE PARTICIPANT
 
ANALYST
 
CORPORATE PARTICIPANT
 
ANALYST
 
CORPORATE PARTICIPANT
 
OPERATOR
 
ANALYST
 
CORPORATE PARTICIPANT
 
CORPORATE PARTICIPANT
 
ANALYST
 
CORPORATE PARTICIPANT
 
JOSEPH PAPA
 
ANALYST
 
JOSEPH PAPA
 
ANALYST
 
CORPORATE PARTICIPANT
 
CORPORATE PARTICIPANT
 
CORPORATE PARTICIPANT
 
ANALYST
 
CORPORATE PARTICIPANT
 
CORPORATE PARTICIPANT
 
CORPORATE PARTICIPANT
 
ANALYST
 
CORPORATE PARTICIPANT
 
JOSEPH PAPA
 
ANALYST
 
CORPORATE PARTICIPANT
 
CORPORATE PARTICIPANT
 
ANALYST
 
CORPORATE PARTICIPANT
 
ANALYST
 
CORPORATE PARTICIPANT
 
ANALYST
 
CORPORATE PARTICIPANT
 
ANALYST
 
CORPORATE PARTICIPANT
 
 
 
 
 
 

/Users/nsuaifan/Desktop/sample/WATSON PHARMACEUTICALS 2008 Q4.txt
________________
 
 
OPERATOR
 
 
PATTY EISENHAUR, DIRECTOR OF IR, WATSON PHARMACEUTICALS, INC.
 
 
 
 
PAUL BISARO, PRESIDENT, CEO, WATSON PHARMACEUTICALS, INC.
 
 
 
 
 
 
 
 
 
 
 
MARK DURAND, CFO, WATSON PHARMACEUTICALS, INC.
 
 
 
 
 
 
 
 
PAUL BISARO
 
 
 
 
PATTY EISENHAUR
 
OPERATOR
 
 
PAUL BISARO
 
GREG GILBERT, ANALYST, BANC OF AMERICA
 
PAUL BISARO
 
GREG GILBERT
 
PAUL BISARO
 
GREG GILBERT
 
PAUL BISARO
 
GREG GILBERT
 
PAUL BISARO
 
OPERATOR
 
COREY DAVIS, ANALYST, NATIXIS
 
PAUL BISARO
 
COREY DAVIS
 
PAUL BISARO
 
COREY DAVIS
 
OPERATOR
 
TIM CHIANG, ANALYST, FTN EQUITY CAPITAL
 
PAUL BISARO
 
TIM CHIANG
 
PAUL BISARO
 
TIM CHIANG
 
PAUL BISARO
 
TIM CHIANG
 
OPERATOR
 
PAUL BISARO
 
RICH SILVER, ANALYST, BARCLAYS CAPITAL
 
PAUL BISARO
 
RICH SILVER
 
PAUL BISARO
 
RICH SILVER
 
PAUL BISARO
 
RICH SILVER
 
PAUL BISARO
 
RICH SILVER
 
OPERATOR
 
RONNY GAL, ANALYST, SANFORD BERNSTEIN
 
PAUL BISARO
 
RONNY GAL
 
PAUL BISARO
 
 
 
RONNY GAL
 
PAUL BISARO
 
RONNY GAL
 
OPERATOR
 
ELLIOT WILBUR, ANALYST, NEEDHAM & CO
 
PAUL BISARO
 
ELLIOT WILBUR
 
PAUL BISARO
 
ELLIOT WILBUR
 
PAUL BISARO
 
ELLIOT WILBUR
 
OPERATOR
 
RANDALL STANICKY, ANALYST, GOLDMAN SACHS
 
PAUL BISARO
 
RANDALL STANICKY
 
PAUL BISARO
 
RANDALL STANICKY
 
PAUL BISARO
 
RANDALL STANICKY
 
PAUL BISARO
 
RANDALL STANICKY
 
PAUL BISARO
 
RANDALL STANICKY
 
OPERATOR
 
CAIUS CHRISTOE, ANALYST, MORGAN STANLEY
 
PAUL BISARO
 
 
CAIUS CHRISTOE
 
PAUL BISARO
 
CAIUS CHRISTOE
 
PAUL BISARO
 
CAIUS CHRISTOE
 
PAUL BISARO
 
CAIUS CHRISTOE
 
PAUL BISARO
 
CAIUS CHRISTOE
 
OPERATOR
 
MICHAEL TONG, ANALYST, WACHOVIA CAPITAL
 
PAUL BISARO
 
MICHAEL TONG
 
PAUL BISARO
 
MICHAEL TONG
 
PAUL BISARO
 
MICHAEL TONG
 
OPERATOR
 
JOHN BORIS, ANALYST, CITIGROUP
 
PAUL BISARO
 
JOHN BORIS
 
PAUL BISARO
 
JOHN BORIS
 
PAUL BISARO
 
JOHN BORIS
 
PAUL BISARO
 
JOHN BORIS
 
PAUL BISARO
 
JOHN BORIS
 
PAUL BISARO
 
JOHN BORIS
 
PAUL BISARO
 
JOHN BORIS
 
PAUL BISARO
 
JOHN BORIS
 
PATTY EISENHAUR
 
OPERATOR
 
 
 
THE INFORMATION CONTAINED IN EVENT TRANSCRIPTS IS A TEXTUAL REPRESENTATION OF THE APPLICABLE COMPANY'S CONFERENCE CALL AND WHILE EFFORTS ARE MADE TO PROVIDE AN ACCURATE TRANSCRIPTION, THERE MAY BE MATERIAL ERRORS, OMISSIONS, OR INACCURACIES IN THE REPORTING OF THE SUBSTANCE OF THE CONFERENCE CALLS. IN NO WAY DOES THOMSON FINANCIAL OR THE APPLICABLE COMPANY OR THE APPLICABLE COMPANY ASSUME ANY RESPONSIBILITY FOR ANY INVESTMENT OR OTHER DECISIONS MADE BASED UPON THE INFORMATION PROVIDED ON THIS WEB SITE OR IN ANY EVENT TRANSCRIPT. USERS ARE ADVISED TO REVIEW THE APPLICABLE COMPANY'S CONFERENCE CALL ITSELF AND THE APPLICABLE COMPANY'S SEC FILINGS BEFORE MAKING ANY INVESTMENT OR OTHER DECISIONS.]
 
 
